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Abstract
Background: Patient noncompliance with therapy, treatments, and appointments represents a significant barrier to improving
health care delivery and reducing the cost of care. One method to improve therapeutic adherence is to improve feedback loops
in getting clinically acute events and issues to the relevant clinical providers as necessary (ranging from detecting hypoglycemic
events for patients with diabetes to notifying the provider when patients are out of medications). Patients often don’t know which
information should prompt a call to their physician and proactive checks by the clinics themselves can be very resource intensive.
We hypothesized that a two-way SMS system combined with a platform web service for providers would enable both high patient
engagement but also the ability to detect relevant clinical alerts.
Objective: The objectives of this study are to develop a feasible two-way automated SMS/phone call + web service platform
for patient-provider communication, and then study the feasibility and acceptability of the Epharmix platform. First, we report
utilization rates over the course of the first 18 months of operation including total identified clinically significant events, and
second, review results of patient user-satisfaction surveys for interventions for patients with diabetes, COPD, congestive heart
failure, hypertension, surgical site infections, and breastfeeding difficulties.
Methods: To test this question, we developed a web service + SMS/phone infrastructure (“Epharmix”). Utilization results were
measured based on the total number of text messages or calls sent and received, with percentage engagement defined as a patient
responding to a text message at least once in a given week, including the number of clinically significant alerts generated. User
satisfaction surveys were sent once per month over the 18 months to measure satisfaction with the system, frequency and degree
of communication. Descriptive statistics were used to describe the above information.
Results: In total, 28,386 text messages and 24,017 calls were sent to 929 patients over 9 months. Patients responded to 80% to
90% of messages allowing the system to detect 1164 clinically significant events. Patients reported increased satisfaction and
communication with their provider. Epharmix increased the number of patient-provider interactions to over 10 on average in any
given month for patients with diabetes, COPD, congestive heart failure, hypertension, surgical site infections, and breastfeeding
difficulties.
Conclusions: Engaging high-risk patients remains a difficult process that may be improved through novel, digital health
interventions. The Epharmix platform enables increased patient engagement with very low risk to improve clinical outcomes.
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We demonstrated that engagement among high-risk populations is possible when health care comes conveniently to where they
are.
(JMIR Formativ Res 2017;1(1):e2) doi: 10.2196/formative.7211
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Introduction

messages of all PHI, obtaining informed consent, phone
line-specific consenting, and using secure servers.

There has been significant interest in the digital health field to
use automated and digital health techniques to facilitate scalable,
proactive patient outreach. Many attempts have been made using
Health Insurance Portability and Accountability Act
(HIPAA)-secure application and portal environments to engage
patients in their care under encrypted safe harbor provisions as
defined by the Health Information Technology for Economic
and Clinical Health Act (HITECH) [1-5]. Although these
applications may be convenient for some providers and patients,
for other patients—particularly those who tend to be
nonadherent,
high-resource
users
and
Medicaid
beneficiaries—application and portal usage can be a significant
burden due to lack of Internet access, mobile data costs,
downloading mechanics, or time required for implementation
[2,6-9].

The Epharmix system possesses several key features to
maximize data security and protect patient and provider privacy.
Figure 1 describes the organization of data flow in the system.
A detailed description of individual disease specific algorithms
and interventions can be found on www.epharmix.com. These
include building a combination of security measures including
infrastructure, identifier removal, clinically relevant surveys,
clinical data reporting, voluntary opt-out, toll-free messaging,
customizable message frequency, consent confirmation, and
time tracking, that are all built into the software. In addition,
with our clinical partners we built a process infrastructure
including a business associate agreement (BAA), patient
consent, and provider workflow. Each of these is described
more thoroughly below.

To do our utmost to help these patients per the provisions of
HIPAA, we devised a method that uses widely existing
infrastructure to meet patient care needs. Almost all (97%)
patients carry a cell phone, and 85% of homeless veterans carry
a cell phone [10-12]. All cell phones come with both voice and
short message service (SMS) applications preinstalled. All
landlines can carry a voice application. Newly developed voice
on the cloud technology has allowed us to build an automated
software platform that contacts patients en masse with the
additional attribute of being toll-free, allowing us to reach
low-income patients who may not have minutes or texts
available for other purposes. The software platform that our
team developed is called Epharmix, and it was implemented at
Washington University in St. Louis as a quality improvement
initiative.
Although phone calls fall under the safe harbor provisions of
the HITECH act, making them automated means that they must
meet the requirements put forward by the Federal
Communications Commission (FCC) under the Telephone
Consumer Protection Act (TCPA) [13-15]. Additionally, due
to HIPAA constraints, the content of the messages must be
strictly controlled to mitigate the risk of breach of protected
health information (PHI) [16,17].
We found that for patients older than 65 years, phone calls were
an appropriate and effective means to contact patients. However,
for patients under 65 years, text messages are generally seen as
a more effective medium for communication. In our system,
SMS messages come from toll-free numbers to the patients and
on request can be made free to the end user, but SMS messages
are intrinsically unencrypted. To mitigate the risk of a reportable
breach, we developed a series of measures including scrubbing
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We developed the Epharmix platform with both high availability
and patient security in mind. The Epharmix stack was deployed
on servers provided by an industry-leading, Health Information
Trust Alliance–certified hosting provider. The environment was
hardened on the operating system level and included features
such as around the clock penetration monitoring, distributed
denial of service mitigation, intelligent intellectual property
reputation filters, and additional security measures. All data
held were placed in file encryption vaults using the AES-256
encryption algorithm; the vaults were managed by a role-based
access control system to ensure maximum security. Finally,
following log-in, a log-out timer automatically logs the user out
of the website after it has been idle for over 30 minutes.
Strict control of the messaging was implemented with all
messages pre-vetted and any identifiers removed, ensuring that
providers could not send identifying information via either SMS
or phone call versions. Messages from patients were restricted
to numerical values, single letter, or yes/no answers; no
free-form text responses were allowed. This further mitigated
the risk of the patient disclosing their own PHI.
Working directly with clinicians, we built a library of 20
disease-specific surveys capable of identifying signs and
symptoms across various patient populations. These surveys
trigger alerts and reports that providers can review in order to
improve clinical management. Providers received alerts via
email, text message, page, or phone call when urgent data were
ready for their review. These alerts contained no PHI but still
relayed the pertinent data necessary to maintain clinical
usefulness. Providers were able to access identifiable data by
logging in to the secure Web-based portal. Data from the patient
regarding patient-reported signs and symptoms can be stored
in the Epharmix portal or transferred into the appropriate
electronic medical record (EMR). A voluntary opt-out of the
JMIR Formativ Res 2017 | vol. 1 | iss. 1 | e2 | p. 2
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service was built into Epharmix to respond to a patient replying
“STOP” or pressing the asterisk on his or her phone. This feature
cancels all future messages and ensures compliance with federal
communication commission regulations.
Phone calls are initiated from a toll-free number to remove any
fees that may otherwise be charged to the patient, whether from
a cell phone or a landline. Additionally, a free-to-end-user
service makes all SMS text messages free to the end user
through the use of an approved short code messaging sequence
within the Epharmix software algorithm. For some patients,
standard messaging charges may still apply based on their
specific mobile plans, but every effort is made to remove these
fees.
Message frequency and timing is controlled by the patient
initially. In addition, a smart frequency algorithm can modulate
the frequency based on the patient’s self-reported condition, for
instance: when a patient reports values within the provider set
thresholds, the message frequency is decreased in order to
prevent user fatigue. Likewise, the smart system will also
increase message frequency if the clinical thresholds are
breached (e.g. fasting blood glucose > 400 mg/dL or >2 events
of paroxysmal nocturnal dyspnea or fluid weight gain in heart
failure, among others).
To initiate an Epharmix outward message, providers must
confirm that they consented the patient. Then, Epharmix
confirms the patient’s identity and informed consent by asking
the first name without including any other identifiers or health
information. If a patient does not confirm their acceptance to
begin receiving messages, the prescribing provider is notified
and the patient is sent no further messages.
Finally, as an added feature, Epharmix tracks all time spent by
provider and patient on the phone when using the Epharmix
system. The time providers spend managing their patients over
the phone can be submitted for reimbursement through newly
created chronic care management billing codes. Epharmix
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creates patient time logs that track the amount of time spent in
communication with each patient, which can be used as proof
of service when filing for reimbursement.
To implement in the clinic a series of process innovations also
needed to be made, including developing a business associate
agreement between Epharmix, Inc. and its healthcare
implementation sites to allow for data sharing and to define data
ownership, as well as defining how patients should consent and
how providers would access the data.
Per the implementation site policy, a written authorization form
which relayed the risks of unencrypted messaging was required
to begin sending SMS messages to patients. For patients not
using SMS messages, verbal consent to reach them via
automated phone calls was sufficient to begin messages.
Providing reliable and timely reports to providers was a central
focus of the Epharmix design. Assistance to providers in viewing
their patients’ Epharmix data was accomplished through two
key methods. The Epharmix software tracks if a provider called
their patient or if an alert has already been resolved. For many
disease systems, patients are triaged into red, yellow, and green
categories based on their self-reported disease severity. For
example, patients with diabetes are sorted according to a moving
average of their blood glucose values in the past week. This
triage system allows providers to focus their calls on the patients
in greatest need of their attention at any time.
At 18 months after system implementation, patients using
Epharmix demonstrate a 2- to 3-fold increase in response rate
compared to general EMR portal usage [18-20]. The results
demonstrate a basal weekly response rate of approximately 80%
to both text and phone call messages, with up to a 95% response
rate depending on the message frequency and particular disease
focus. Additionally, Epharmix messages are already being used
for the early detection and intervention of clinically significant
events such as chronic obstructive pulmonary disease (COPD)
exacerbations, heart failure decompensation, and hypoglycemia.

Figure 1. Patient data flow between provider and patient in Epharmix system.
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Methods
Overview
Epharmix was developed as an iterative process of design and
feedback within the Sling Health (formerly IDEA Labs)
innovation incubator at Washington University in St. Louis
[21]. A combination of software and process development was
used to build a system in compliance with all current healthcare,
privacy, and communication regulations. The data reported
herein is an aggregate analysis of de-identified data from
enrollment in quality improvement projects and randomized
controlled trials utilizing the Epharmix system currently
underway that was reviewed and approved by the Washington
University in St. Louis Institutional Review Board. Three of
these studies are currently in press or published [22-26].
Individual analysis of disease specific outcomes and
interventions is reported separately. This study reports on the
engineering and development of the platform as a whole and
its subsequent utilization and feasibility for use in the clinic.

Study Design: Patient Engagement and Satisfaction
Analysis
All patients who used Epharmix also received a patient
satisfaction survey once per month via text message as part of
the implementation. Aggregate deidentified data of the use of
Epharmix at Washington University was reported from
Epharmix and used in this analysis. No patient specific records
were reviewed in this analysis. Because of the aggregate nature
of the data across multiple specialties, socioeconomic data could
not be collected or analyzed for this particular utilization study.
The majority of patients were all adults from St. Louis City and
County, and census data for socioeconomic status is reported
as a corollary in Table 1 (US Census).

Som et al

Measures
Number of text messages/phone calls sent and received is
defined as the number successfully sent and received from
Epharmix. Patients were defined as “not engaged weekly” if
they responded 0 times, and they were defined as “engaged
weekly” if they responded 1 or more times in a week. The
weekly percentage engagement was then the percentage of
patients who were “engaged weekly” in any given week as
defined above. Similarly, we also calculated the percentage of
patients who were engaged monthly by defining “engaged
monthly” as responding to 1 or more messages in a month. And
then the monthly percentage engagement was then the
percentage of patients who were “engaged monthly” in any
given week as defined above. Alerts are defined per disease
specific intervention and are considered clinically significant
if a patient’s response is above or below clinically set thresholds,
such as a blood glucose > 400. Patient satisfaction with their
provider using the service was defined based on a Likert scale
from 0-9, with 0 being the worst and 9 being the best. Message
frequency was also assessed on a 0 to 9 scale, albeit with 5 being
perfect, 0 being too few, and 9 being too many. Finally, patients
also report the degree to which the system improved
communication with their provider on a 0 to 9 basis where 0 is
greatly reduced, 5 is stayed the same, and 9 is greatly improved.

Analysis
Data on engagement and use were analyzed after 18 months of
use across a series of disease-specific quality improvement
projects and RCTs aimed at improving disease-specific
outcomes. Engagement to the Epharmix system reported herein
was compared to engagement in the literature seen with health
care portals using descriptive statistics.

Table 1. St. Louis city and county residents demographic and income data from which the Epharmix population was recruited (US Census).
Characteristics

St. Louis city

St. Louis county

Age 18-65 years, %

61.2

55.2

Age >65 years, %

11

16.8

Male, %

48.3

47.7

Female, %

51.7

52.3

White, %

43.9

69.5

African American, %

49.2

24.1

Median household income 2011-2015

$35,599

$59,755

Results
Software Development
The user interface of Epharmix inhibits the sending of messages
without a confirmation of consent by the patient as noted in
Figure 2 below. This checkbox verification feature reduces the
risk of messaging without consent and builds in safeguards for
compliance with both HIPAA and TCPA.
Using the methods described above, this process has facilitated
the completion of 52,403 phone calls (46%) and text messages
(54%). Messages do not contain any identifiers, and this
http://formative.jmir.org/2017/1/e2/
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mitigates the risk of a text message or phone call releasing PHI
to an incorrect person in cases where the phone number entered
into the Epharmix system is incorrect. At the same time, text
messages and phone calls are easier for patients to use, fitting
more into their activities of daily living as compared with more
traditional mailers, fliers, or Web-based portals.

Patient Engagement
We find a significant number of engagements, with an average
of 13 bidirectional message exchanges with individual patients
via text or phone calls per month. Monthly engagement rates
have been stable at 80% to 90%, even as the number of patients
JMIR Formativ Res 2017 | vol. 1 | iss. 1 | e2 | p. 4
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on Epharmix has steadily risen (Figure 3). Over the entire
course, 14.5% of patients explicitly opted out of usage of the
service. Although not directly comparable, these engagement
rates may suggest higher patient engagement than that seen in
portal usage alone in the literature [19,20].

Satisfaction
We find that these engagements tend to increase overall
satisfaction with patients’ providers (8.4/9), and patients report
an increased degree of communication with their provider
(7.3/9). In this survey, a response of 5 referred to the same level
of satisfaction or communication, 9 represented more, and less
than 5 represented less. A majority of patients felt the frequency
of messages was about perfect even as the absolute number of
engagements in a year with their provider increased from an
average of 3 office visits to about 23 times in a year while using
Epharmix (Figure 4).

Som et al

Clinically Actionable Events
Out of the 52,403 messages sent and received over the course
of nine months, there were 1,164 clinically significant events
caught, including diabetic hypoglycemia and hyperglycemia,
COPD exacerbations, heart failure decompensations,
hypertensive crises, wound infections, and breastfeeding
complications. These were triggered whenever a patient’s
responses crossed any of the thresholds as described in Table
2. Once caught by the Epharmix automated system, proactive
care was able to be provided as deemed appropriate by the
patient’s specific provider. Accomplishing this degree of
proactive care through an alternative method, such as a provider
initiated phone bank, would be cost prohibitive and most likely
associated with lower patient engagement [27-29].

Figure 2. In the unauthorized state, Epharmix will not allow a person to receive the automated message. Once authorized, patients may begin receiving
Epharmix automated messages.

Figure 3. Average number of patient engagements with Epharmix (left) and percentage of patients responding to Epharmix interventions (right).
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Figure 4. Average patient feedback scores (left) and message frequency feedback ratings (right).

Table 2. Types of clinically significant events identified during the first 18 months of the study.
Intervention

Clinical event

Diabetes

Hypoglycemia (fasting blood glucose <70 mg/dL)
Hyperglycemia (fasting blood glucose >400 mg/dL)

Chronic obstructive pulmonary disease

Worsening Dyspnea
Fluid overload: increases in weight (>5 lbs over 1 week as compared to baseline)

Congestive heart failure

Hypertensive crisis (blood pressure >180/110 mm Hg)
Hypertensive urgency (blood pressure >180/120 mm Hg)
Tachycardia (heart rate >100 bpm)
Worsening dyspnea, orthopnea, or pedal edema

Hypertension

Hypertensive crisis (blood pressure >180/110 mm Hg)
Hypertensive urgency (blood pressure >180/120 mm Hg)

Decolonization

Failure to accept prescribed supplies

Wound

Signs of Infection (worsening pain, drainage, redness, and fever)

Breastfeeding

Patient not exclusively breastfeeding
Breastfeeding associated (eg, breast pain, difficulty latching, not producing enough milk, insufficient
child weight gain)

Discussion
Principal Findings
Building an automated text messaging and phone call system
to engage, monitor, and aid patients throughout their care
process fundamentally increases engagement. Patients clearly
are satisfied with the increased degree of engagement with their
providers, and based on our results, find the increased frequency
of interactions to be reasonable. The number of clinically
significant events identified by this proactive care system
emphasizes the utility of distributing accessible electronic
messaging systems to patients in traditionally medically
underserved areas.
Epharmix provides an example of a solution capable of engaging
patients using ubiquitous text messages and phone calls. These
lines of communication provide valuable and direct contact
approaches, as 80% of cell phone users send and receive text
http://formative.jmir.org/2017/1/e2/
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messages [30]. The ability to combine smart algorithmic
methods across populations makes this technology much more
powerful. Given the high penetration rate of cellphones and
landlines among all socioeconomic strata, particularly those
with lower incomes, the system enables potentially greater
engagement by that otherwise difficult-to-reach patient
population.

Limitations
In focusing on developing a system that uses a widespread
infrastructure, landlines and cell phones, the system does remain
limited in that it does not reach patients who do not have access
to landlines or cell phones. Moreover, it does not take advantage
of higher end smartphone features such as video conferencing
or using Web links. These are possible future features to add to
the system as the underlying smartphone technology becomes
more standardized, cheaper, and prevalent in older and lower
socioeconomic strata.
JMIR Formativ Res 2017 | vol. 1 | iss. 1 | e2 | p. 6
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This study does not determine whether the high engagement
correlates to improved clinical outcomes, and we could not
correlate the engagement with satisfaction directly because the
data is deidentified and all the clinical conditions are aggregated.
Because of the aggregate nature of this study we were unable
to assess engagement rates by disease states. We are only
observing user statistics and so do not know about nonuser
health engagement and use, and finally we lack demographic
data to make correlations between age and socioeconomic status
and engagement. The series of quality improvement projects
and RCTs on which this meta-analysis is based will report
whether the increased engagement and early detection of
clinically significant events associated with Epharmix will
improve underlying clinical outcomes.

Conclusions
Using accepted means for mitigating risk, we have been able
to create a method using ubiquitous and patient-accessible forms

Som et al
of communication—SMS and phone calls—to improve patient
engagement, satisfaction, and the capacity for remote
monitoring. We find a significantly increased patient
engagement rate that has allowed for the identification of
numerous clinically significant events that may otherwise have
been missed. The use of this monitoring system allows for the
early detection and intervention of clinically significant events
within the confines of all compliance requirements. In the
context of the literature, great progress has been made in
developing 1- and 2-way patient-facing portals, mobile phone
apps, and even texting [5,11,20,27]. Developing a two way
automated SMS system across multiple disease states is still a
challenge for both technical, and security based reasons. The
system described enables the use of automated SMS and phone
calls to help increase patient engagement feasibly and increase
two way feedback loops across multiple disease states. Future
directions include analysis per specific disease state and
randomized controlled trials to study the impact.
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